Market research
1N9.F NeutriSci International Inc
F EUR Healthcare
Latest close
As of 14 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 600K
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.84
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA64129Y1079
- Market cap
- 600K
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.84
About
About NeutriSci International Inc
NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Research context
NeutriSci International Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 1N9.F discussion.
5 years, 6 months ago
NeutriSci International Inc is currently in a long term uptrend where the price is trading 1.5% above its 200 day moving average.
From a valuation standpoint, the stock is 74.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 332.6.
NeutriSci International Inc's total revenue rose by 68.8% to $60K since the same quarter in the previous year.
Its net income has dropped by 119.6% to $-633K since the same quarter in the previous year.
Finally, its free cash flow grew by 53.4% to $-274K since the same quarter in the previous year.
Based on the above factors, NeutriSci International Inc gets an overall score of 4/5.